These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 593260)

  • 1. The pseudoirreversible inhibition of monoamine oxidase by allylamine.
    Rando RR; Eigner A
    Mol Pharmacol; 1977 Nov; 13(6):1005-13. PubMed ID: 593260
    [No Abstract]   [Full Text] [Related]  

  • 2. Inactivation of monoamine oxidase by allylamine does not result in flavin attachment.
    Silverman RB; Hiebert CK; Vazquez ML
    J Biol Chem; 1985 Nov; 260(27):14648-52. PubMed ID: 4055794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationship studies of neuronal monoamine uptake inhibition of pyridylallylamines.
    Singh P
    Indian J Biochem Biophys; 1984 Dec; 21(6):406-8. PubMed ID: 6545533
    [No Abstract]   [Full Text] [Related]  

  • 4. (Z)-2-(2,4-Dichlorophenoxy)methyl-3-fluoroallylamine (MDL 72638): a clorgyline analogue with surprising selectivity for monoamine oxidase type B.
    McDonald IA; Palfreyman MG; Zreika M; Bey P
    Biochem Pharmacol; 1986 Jan; 35(2):349-51. PubMed ID: 3753647
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative study of catalytic properties of the liver monoamine oxidase from the squid Todarodes pacificus and the Wistar rat].
    Iagodina OV; Basova NE
    Zh Evol Biokhim Fiziol; 2001; 37(3):175-9. PubMed ID: 11605436
    [No Abstract]   [Full Text] [Related]  

  • 6. [Conjugated dinitrocompound dianions as inhibitors of the oxidative deamination of monoamines].
    Gureeva ZP; Mostiaeva LV
    Biokhimiia; 1984 Nov; 49(11):1840-6. PubMed ID: 6549266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revised mechanism for inactivation of mitochondrial monoamine oxidase by N-cyclopropylbenzylamine.
    Vazquez ML; Silverman RB
    Biochemistry; 1985 Nov; 24(23):6538-43. PubMed ID: 4084536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The labeling in vivo of monoamine oxidase by 14 C-pargyline: a tool for studying the synthesis of the enzyme.
    Erwin VG; Deitrich RA
    Mol Pharmacol; 1971 Mar; 7(2):219-28. PubMed ID: 5125856
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies of mitochondrial monoamine oxidase. Inactivation of the enzyme by isomeric acetylenic and allenic amines yielding muturally exclusive products.
    Krantz A; Lipkowitz GS
    J Am Chem Soc; 1977 Jun; 99(12):4156-9. PubMed ID: 864109
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of some derivatives of piperidine, piperazine and related compounds on deamination of serotonin, tyramine and benzylamine by pig liver mitochondrial monoamine oxidase].
    Prikulis AA; Grinberga BA; Grinshteĭn VIa; Strelka GR
    Biokhimiia; 1983; 48(2):313-9. PubMed ID: 6838929
    [No Abstract]   [Full Text] [Related]  

  • 11. Steric influence on inhibition of monoamine oxidase forms by 2,3-dichloro-alpha-methylbenzylamine.
    Fuller RW; Hemrick SK
    Res Commun Chem Pathol Pharmacol; 1978 Apr; 20(1):199-202. PubMed ID: 663404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3-Bromoallylamine induced irreversible inhibition of monoamine oxidase.
    Rando RR
    J Am Chem Soc; 1973 Jun; 95(13):4438-9. PubMed ID: 4736100
    [No Abstract]   [Full Text] [Related]  

  • 13. N-(1-Methyl)cyclopropylbenzylamine: a novel inactivator of mitochondrial monoamine oxidase.
    Silverman RB; Hoffman SJ
    Biochem Biophys Res Commun; 1981 Aug; 101(4):1396-401. PubMed ID: 7306137
    [No Abstract]   [Full Text] [Related]  

  • 14. [The importance of substrate structure in selective inhibition of mitochondrial monoamine oxidase activity by several inhibitors].
    Severina IS
    Biokhimiia; 1973; 38(3):608-15. PubMed ID: 4798599
    [No Abstract]   [Full Text] [Related]  

  • 15. Multiple forms of mitochondrial monoamine oxidase.
    Diaz Borges JM; D'Iorio A
    Adv Biochem Psychopharmacol; 1972; 5():79-89. PubMed ID: 4559892
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-inflammatory effects of LJP 1586 [Z-3-fluoro-2-(4-methoxybenzyl)allylamine hydrochloride], an amine-based inhibitor of semicarbazide-sensitive amine oxidase activity.
    O'Rourke AM; Wang EY; Miller A; Podar EM; Scheyhing K; Huang L; Kessler C; Gao H; Ton-Nu HT; Macdonald MT; Jones DS; Linnik MD
    J Pharmacol Exp Ther; 2008 Feb; 324(2):867-75. PubMed ID: 17993604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of activity of semicarbazide-sensitive aminooxidases and cellular glutathione on the cytotoxic effect of allylamine, acrolein, and formaldehyde in human cultured endothelial cells].
    Pino R; Lyles GA
    Vopr Med Khim; 1997; 43(6):537-47. PubMed ID: 9503571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative ex vivo inhibitory effects of (E)-2-(3,4-dimethoxyphenyl)-3-fluoroallylamine (MDL 72145) on amine oxidase activities in the rat.
    Lyles GA; Marshall CM; Flucker CJ
    Biochem Pharmacol; 1989 Sep; 38(17):2937-40. PubMed ID: 2775316
    [No Abstract]   [Full Text] [Related]  

  • 19. The monoamine oxidase inhibitory effect of new homopyrimidazole derivatives.
    Magyar K; Satory E; Meszaros Z
    Med Biol; 1974 Dec; 52(6):384-9. PubMed ID: 4444359
    [No Abstract]   [Full Text] [Related]  

  • 20. [Sulfhydryl groups in mitochondrial monoamine oxidase activity].
    Kliashtorin LB; Gridneva LI
    Biokhimiia; 1966; 31(4):831-9. PubMed ID: 5999967
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.